Hsa-miR-206 inhibits the migration and invasion of breast cancer by targeting Cx43

National Medical Journal of China

Volumn 93, Issue 36, 2013, Pages 2890-2894

  Fu, Yun ^a   Jiang, Bei Qi ^a   Wu, Yi ^a   Li, Zheng Dong ^a   Zhuang, Zhi Gang ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast neoplasms; Connexin43; Hsa miR 206; Invasion; Migration

Indexed keywords

BREAST CANCER METASTASIS SUPPRESSOR 1; CONNEXIN 43; GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 206; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR INVASION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CONNEXIN 43; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOPLASM PROTEINS; TRANSFECTION;

EID: 84886739160     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.36.011     Document Type: Article

References (12)

1. 2010, 90: 281-284.
2. Budhu A, Ji J, Wang X W. The clinical potential of microRNAs. J Hematol Oncol, 2010, 3: 37.
3. Goldhirsch A, Wood W C, Coates A S. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 2011, 22: 1736-1747.
4. Hidaka H, Seki N, Yoshino H, et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget, 2012, 3: 44-57.
5. Vickers M M, Bar J, Gorn-Hondermann I, et al. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis, 2012, 29: 123-132.
6. Zhang T, Liu M, Wang C, et al. Down-regulation of Hsa-miR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res, 2011, 31: 3859-3863.
7. Chen X, Yan Q, Li S, et al. Expression of the tumor suppressor hsa-miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERa-positive endometrioid adenocarcinoma. Cancer Lett, 2012, 314: 41-53.
8. Kondo N, Toyama T, Sugiura H, et al. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res, 2008, 68: 5004-5008.
9. Yang L, Wu X, Wang Y, et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene, 2011, 30: 4437-4446.
10. Stratford A L, Reipas K, Hu K, et al. Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers. Stem Cells, 2012, 30: 1338-1348.
11. Chen X, Xu Z, Wang Y. Recent advances in breast cancer metastasis suppressor 1. Int J Biol Markers, 2011, 26: 1-8.
12. 2012, 20: 1953-1956.